Literature DB >> 9894753

Quality of life and end stage renal disease therapeutic programs. DIA-QOL Group. Dialysis quality of life.

G Mingardi1.   

Abstract

Because patients with ESRD cannot be cured of their underlying conditions and because the therapeutic programs have an important impact on the patients' life style, the patient's own assessment of health should have a central place in clinical care. Until now, attention has almost exclusively focused on technical and clinical outcomes, and survival. Functional status, well-being and quality of life, satisfaction with care, or in other words "patient's experience", have been only marginally considered. There is a growing recognition that use of mortality data alone is not the most effective way to asses the quality of care provided to these patients. Generic and disease-specific health issues can be investigated with the use of questionnaires, by asking questions that cover physical, psychological and social domains. Health related quality of life data regarding chronic renal failure, dialysis and transplantation are briefly presented and discussed. These data show differences between patient's subjective feelings and physician's opinions about patients, between objective quality of life indexes and subjective quality of life scores. A more comprehensive view of our patients seems possible and useful.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9894753

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  4 in total

Review 1.  Energy homeostasis and cachexia in chronic kidney disease.

Authors:  Robert H Mak; Wai Cheung
Journal:  Pediatr Nephrol       Date:  2006-08-01       Impact factor: 3.714

Review 2.  Psychopathological aspects of kidney transplantation: Efficacy of a multidisciplinary team.

Authors:  Concetta De Pasquale; Massimiliano Veroux; Luisa Indelicato; Nunzia Sinagra; Alessia Giaquinta; Michele Fornaro; Pierfrancesco Veroux; Maria L Pistorio
Journal:  World J Transplant       Date:  2014-12-24

3.  Transplant Patients' Isolation and Social Distancing Because of COVID-19: Analysis of the Resilient Capacities of the Transplant in the Management of the Coronavirus Emergency.

Authors:  Diana Lupi; Barbara Binda; Filippo Montali; Andrea Natili; Laura Lancione; Davide Chiappori; Ida Parzanese; Daniela Maccarone; Francesco Pisani
Journal:  Transplant Proc       Date:  2020-05-30       Impact factor: 1.066

4.  An Evidence-Based Theory About PRO Use in Kidney Care: A Realist Synthesis.

Authors:  Kara Schick-Makaroff; Adrienne Levay; Stephanie Thompson; Rachel Flynn; Richard Sawatzky; Onouma Thummapol; Scott Klarenbach; Mehri Karimi-Dehkordi; Joanne Greenhalgh
Journal:  Patient       Date:  2021-06-10       Impact factor: 3.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.